Nakamaki T - Search Results

1

Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome.

Baba Y, Saito B, Shimada S, Sasaki Y, Murai S, Abe M, Fujiwara S, Arai N, Kawaguchi Y, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Hattori N, Harada H, Nakamaki T. Baba Y, et al. Among authors: nakamaki t. Leuk Res. 2018 Apr;67:56-59. doi: 10.1016/j.leukres.2018.02.004. Epub 2018 Feb 7. Leuk Res. 2018. PMID: 29433052 Free article.

2

Inhibition of granulocytic differentiation of acute promyelocytic leukemia cells in primary culture by transforming growth factor-beta.

Nakamaki T, Hino K, Tomoyasu S, Honma Y, Hozumi M, Tsuruoka N. Nakamaki T, et al. Leuk Res. 1993 Dec;17(12):1051-6. doi: 10.1016/0145-2126(93)90162-e. Leuk Res. 1993. PMID: 7504151

3

[Differentiation therapy for myelodysplastic syndrome].

Hino K, Nakamaki T. Hino K, et al. Among authors: nakamaki t. Rinsho Ketsueki. 1993 Mar;34(3):283-8. Rinsho Ketsueki. 1993. PMID: 7683064 Japanese.

4

Increased proliferation of eosinophil clusters in myelodysplastic syndromes.

Koike M, Ishiyama T, Yokoyama A, Kawakami K, Nakamaki T, Tomoyasu S, Tsuruoka N. Koike M, et al. Among authors: nakamaki t. Leuk Res. 1995 Dec;19(12):915-20. doi: 10.1016/0145-2126(95)00083-6. Leuk Res. 1995. PMID: 8632660

5

Molecular analysis of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 and p19 in the myelodysplastic syndromes.

Nakamaki T, Bartram C, Seriu T, Kahan J, Fukuchi K, Tsuruoka N, Janssen JW, Miller CW, Koeffler HP. Nakamaki T, et al. Leuk Res. 1997 Mar;21(3):235-40. doi: 10.1016/s0145-2126(96)00115-4. Leuk Res. 1997. PMID: 9111168

6

MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia.

Yokoyama A, Yamashita T, Shiozawa E, Nagasawa A, Okabe-Kado J, Nakamaki T, Tomoyasu S, Kimura F, Motoyoshi K, Honma Y, Kasukabe T. Yokoyama A, et al. Among authors: nakamaki t. Leuk Res. 2004 Feb;28(2):149-57. doi: 10.1016/s0145-2126(03)00189-9. Leuk Res. 2004. PMID: 14654079

7

Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia.

Nakamaki T, Kawabata H, Saito B, Matsunawa M, Suzuki J, Adachi D, Tomoyasu S, Phillip Koeffler H. Nakamaki T, et al. Br J Haematol. 2004 Apr;125(1):42-9. doi: 10.1111/j.1365-2141.2004.04866.x. Br J Haematol. 2004. PMID: 15015967 Free article.

8

Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on Ki-67 expression.

Saito B, Shiozawa E, Yamochi-Onizuka T, Adachi D, Nakamaki T, Tomoyasu S, Omine M, Mitsuya T, Takimoto M, Ota H. Saito B, et al. Among authors: nakamaki t. Pathol Int. 2004 Sep;54(9):667-74. doi: 10.1111/j.1440-1827.2004.01678.x. Pathol Int. 2004. PMID: 15363034

9

Acute respiratory distress syndrome during the third infusion of rituximab in a patient with follicular lymphoma.

Saito B, Nakamaki T, Adachi D, Suzuki J, Tomoyasu S. Saito B, et al. Among authors: nakamaki t. Int J Hematol. 2004 Aug;80(2):164-7. doi: 10.1532/ijh97.04047. Int J Hematol. 2004. PMID: 15481446

10

Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group.

Shiozawa E, Takimoto M, Makino R, Adachi D, Saito B, Yamochi-Onizuka T, Yamochi T, Shimozuma J, Maeda T, Kohno Y, Kawakami K, Nakamaki T, Tomoyasu S, Shiokawa A, Ota H. Shiozawa E, et al. Among authors: nakamaki t. Leuk Res. 2006 Jul;30(7):859-67. doi: 10.1016/j.leukres.2005.11.004. Epub 2006 Jan 9. Leuk Res. 2006. PMID: 16406514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters